ESC 365 - Two year follow-up results from AUGMENT-HF: a multicenter randomized controlled clinical trial of the efficacy of left ventricular augmentation with algisyl in the treatment of heart failure.

HFA Premium Access

Two year follow-up results from AUGMENT-HF: a multicenter randomized controlled clinical trial of the efficacy of left ventricular augmentation with algisyl in the treatment of heart failure.

Session: Late Breaking Trials III: Innovative and device therapies

Topic: Miscellaneous

Speaker: Professor A. Stewart Coats (Sydney, AU)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

Add to my library

About the speaker

Professor Andrew Stewart Coats

Heart Research Institute, Sydney (Australia)

112 presentations

22 followers

9 more presentations in this session

The subset of patients with acute heart failure able to secrete relaxin-2 at pregnancy concentrations could have a longer survival.

Speaker: Doctor O. Miro (Barcelona, ES)

Discussion: RELAXIN-2.

The HeartLogic multi-sensor algorithm as an automatic predictor of heart failure events: results from the MultiSENSE Trial.

Speaker: Professor R. Gardner (Clydebank, GB)

Discussion: MultiSENSE.

Cardiopoietic stem cell therapy improved left ventricular remodeling: longitudinal results from the CHART-1 study.

Speaker: Professor J. Teerlink (San Francisco, US)

Access the full session

Late Breaking Trials III: Innovative and device therapies

Speakers: Professor A. Stewart Coats, Doctor O. Miro, Professor R. Gardner, Professor J. Teerlink

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources